0
0
10/26/22 at 12:30pm
Organization
PRNewswire
38 words
0
Comments
/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,...
You are the first to view
https://www.prnewswire.com/news-releases/anixa-biosciences-announces-commencement-of-phase-1b-trial-of-its-breast-cancer-vaccine-at-cleveland-clinic-301659590.html
Create an account
or login to join the discussion